Skip to Main content Skip to Navigation
Poster communications

At Which Point and for Which Reasons Are Oral MTX Formulations Switched to Injectable Ones in RA Patients? Combined Results from 3 Independent Observational and Clinical Trials

Document type :
Poster communications
Complete list of metadatas

https://hal.univ-brest.fr/hal-01950293
Contributor : Geneviève Michel <>
Submitted on : Monday, December 10, 2018 - 4:35:30 PM
Last modification on : Wednesday, August 19, 2020 - 11:17:46 AM

Identifiers

  • HAL Id : hal-01950293, version 1

Citation

Rm Flipo, A. Saraux, Christophe Hudry, C Gaujoux-Viala, E Senbel, et al.. At Which Point and for Which Reasons Are Oral MTX Formulations Switched to Injectable Ones in RA Patients? Combined Results from 3 Independent Observational and Clinical Trials. ACR/ARHP Annual Meeting, Oct 2018, Chicago, United States. 70 (suppl 10) (Abstract 601), Arthritis Rheumatology. ⟨hal-01950293⟩

Share

Metrics

Record views

78